Skip to content

LeMaitre Vascular LMAT Q4 2024 Annual earnings

Reported February 27, 2025 · After market close

Revenue$55.7MMiss by $269.2K
EPS$0.49In line
Revenue estimate$56.0M
EPS estimate$0.49

Next report

Aug 4, 2026 (In 5 days)
Revenue estimate$71.5M
EPS estimate$0.81

Financials

Q4 2024

Income statement

See full
Revenue$55.7M+14.0%
Gross profit$38.6M+16.0%
Operating income$12.9M+25.9%
Net income$11.2M+32.1%
EPS (diluted)$0.48+26.3%

Balance sheet

See full
Cash & equivalents$25.6M+5.5%
Total debt$17.9M-6.2%
Total equity$337.3M+13.2%
Total assets$551.8M+59.1%

Cash flow

See full
Operating cash flow$15.2M+41.3%
CapEx$2.0M+59.8%
Free cash flow$13.1M+38.8%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$2.07B+63.8%
Enterprise value$2.06B+63.9%
P/E47×+5.0×
P/S9.4×+2.9×

Profitability

See full
Gross margin68.6%+3.0pp
Operating margin23.8%+4.8pp
Net margin20%+4.5pp
FCF margin16.9%+1.7pp

Returns & leverage

See full
Return on equity13.9%+3.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+6.6×

Segments

By geography

See full
US$32.9M+11.0%
DE$3.5M+10.4%
CA$3.1M+15.2%
GB$2.9M+10.4%

Versus estimates

Ask the moment LeMaitre Vascular reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did LeMaitre Vascular report Q4 2024 earnings?
LeMaitre Vascular (LMAT) reported Q4 2024 earnings on February 27, 2025 after market close.
What were LeMaitre Vascular's Q4 2024 revenue and EPS?
LeMaitre Vascular reported revenue of $55.7M and eps of $0.49 for Q4 2024.
Did LeMaitre Vascular beat estimates in Q4 2024?
Revenue missed the consensus estimate of $56.0M by $269.2K. EPS beat the consensus estimate of $0.49 by $0.00.
Where can I find LeMaitre Vascular's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001437749-25-005637) directly on SEC EDGAR. The filing index links above go to sec.gov.